Abstract: Uric acid is considered the most significant factor in amelioration of oxidative burden in birds. Uric acid is formed in the terminal reactions of purine degradation by the enzyme xanthine oxidoreductase (XOR). In this study, inosine, a purine precursor, was fed to 3 groups of 5 birds: Group 1 was fed 0 (control), Group 2, 0.6 mols inosine/kg feed (INO) and Group 3, INO treatment plus 50 mg allopurinol/kg BM (INOAL). Allopurinol is a known inhibitor of XOR and thereby reduces uric acid (UA). INOAL birds showed lower total liver XOR activity (p = 0.005) but kidney XOR activity was not affected. Both INO and INOAL treated birds had higher plasma and kidney UA concentrations than controls. Liver uric acid (LUA) was significantly reduced in INOAL birds when compared to other treatments. XOR gene expression was increased (p = 0.007) in the liver tissue of INOAL birds when compared to CON and INO birds. However, there were no significant changes in XOR gene expression in the kidney tissue. To our knowledge, this is the first report of XOR gene expression measured under these conditions. These results suggest that regulation of UA production is tissue dependent. The results also indicate a compensatory effect of allopurinol on XOR gene expression which can be linked to a decrease in antioxidant protection from UA.
INTRODUCTION
Xanthine oxidoreductase (XOR) catalyzes the terminal reactions in purine degradation to uric acid (UA), a potent antioxidant for birds and humans. Specifically, XOR catalyzes the formation of UA from hypoxanthine and xanthine. XOR exists in two interconvertible forms: xanthine oxidase (XO) and xanthine dehydrogenase (XD). In mammals, XOR is predominantly found in the XD form, which can be converted to XO either irreversibly via proteolysis or reversibly by oxidation of the sulfhydryl residues (Hille and Massey, 1981) . In the avian, a low, but detectable activity of XO has been measured in the liver and kidney (Remy and Westerfeld, 1951; Nishino et al., 1989; Harrison, 2002; Carro et al., 2009a) . Despite this discovery, the majority of previous research in birds has focused on activity of XD. XOR reaction products include UA and reactive oxygen species (ROS), specifically the generation of peroxide and superoxide radicals. Both radical types are implicated in exacerbating oxidative damage to various tissues (Galbusera et al., 2006) . In contrast UA is a potent antioxidant in birds (Simoyi et al., 2002; Stinefelt et al., 2005) . In most mammals, uricase converts UA to allantoin before excretion. In birds, humans, reptiles and some higher primates, uricase is absent due to the evolutionary loss of the UOX gene encoding for uricase and therefore UA concentrations in the plasma remain elevated (Oda et al., 2002) . Increased U A concentrations have been shown to reduce oxidative stress (Simoyi et al., 2002) , while a reduction in UA dramatically increases oxidative stress (Klandorf et al., 2001; Carro et al., 2009b) . The gene structure of XOR has been determined in several species including humans, mice, chickens and insects. However, it should be noted that to our knowledge the gene sequences for either XD or XO specifically have not been determined for chickens and only xanthine oxidoreductase has been sequenced. Previous studies have investigated the effects of diet on chicken XD activity (Scholz and Featherston, 1967; Itoh et al., 1978) , developmental patterns of XD in the embryo and the post-hatching period and tissue XOR distribution in broilers (Carro et al., 2009a; Settle et al., 2012) , but to our knowledge little is known about the regulation of XOR gene expression in birds. The gene loci that code for human and mouse XOR have been identified and the associated genes have been assigned to chromosomes 2p 22 and 17 (Harrison, 2002; Cazzaniga et al., 1994) . Drosophila genes tend to be more compact with only four or five exons (Terao et al., 1997) . In mammals the exon-intron structure is highly conserved and contains >60 kb and approximately 36 exons (Xu et al., 1996) . Mammalian and avian cDNA sequences have also been reported. Avians, specifically chickens, have a sequence that corresponds to 1358 amino acids whereas mammalian enzymes have a range from 1330-1335 with approximately 90% homology between themselves (Harrison, 2002) . The Mo-Co binding site is the most conserved of the amino acid sequences and has a liver. Tissues were snap frozen in liquid nitrogen and 94% homology between human, rat and mouse XOR (Xu et al., 1995) . Mutations in the XOR gene in humans, more specifically concerning the XD form, have been linked to inheritable xanthinuria. Inhibition of the XOR enzyme results from feeding allopurinol or oxypurinol, as well as from feeding molybdenum-deficient diets that are high in tungsten (Harrison, 2002) . Allopurinol is used to treat gout and hyperuricemia in humans. In birds, allopurinol decreases plasma uric acid (PUA) levels (Klandorf et al., 2001; Simoyi et al., 2002; Carro et al., 2009b) , but information on its effects on XOR activity is scarce and the effects may be tissue dependent (Woodward et al., 1972; Carro et al., 2009b) . Previous studies in our lab have demonstrated inosine fed with allopurinol can lead to a residual toxic effect in the liver tissue of broilers due to r eduction of UA concentrations within the tissue (Settle et al., 2012) . In order to better understand factors that regulate XOR activity, UA levels were increased by exogenous administration of inosine to broilers. While there was no effect on activity of XOR, it was hypothesized that allopurinol would have a downregulating effect on UA production; however this could potentially have a compensatory effect such that XOR gene expression would increase in response to the reduced antioxidant defense provided by UA.
MATERIALS AND METHODS
All experimental protocols were approved by the West Virginia University Animal Care and Use Committee.
Animals and experimental diets:
Twenty Cobb x Cobb mixed sex chicks at one day of age were donated from Pilgrim's Pride Hatchery (Moorefield, WV) and fed a commercial starter diet until three weeks of age before being offered a commercial grower diet. At 5 weeks of age, 15 birds were selected and divided into 3 homogeneous groups according to their body mass (BM) and PUA concentrations. Each group was randomly assigned to one of 3 treatments CON (control), INO (inosine) and INOAL (inosine with allopurinol). Birds in the control group were fed a commercial broiler diet free of antibiotic additives. Birds in the INO group were provided the control diet supplemented with inosine at a rate of 0.6 mols inosine per kg of feed. Birds in the INOAL group received the control diet containing inosine and allopurinol at 50 mg per kg BM over a short period of time to assess the effect of decreased uric acid on XOR gene expression and activity. This dose of inosine had been previously shown to raise PUA levels in broilers (Simoyi et al., 2002) . Body weight and feed intake were monitored over the experimental period. At the end of the experimental period, birds in each group were euthanized by cervical fracture and tissues were reverse primer (diluted to 5 µ/µL) and 5 µL of nucleasecollected. The right kidney was removed as well as the stored in -80°C until analysis.
cDNA synthesis: Total mRNA from 1 mg of either kidney or liver tissue was extracted using RNA-Bee isolation medium (Tel-Test, TX) and quantified using a Genequant spectrophotometer. Quality was assessed using a denaturing formaldehyde-agarose gel. First strand cDNA was synthesized by using Life Technologies' Superscript II Indirect cDNA Labeling System Life, Carlsbad, CA) according to the manufacturer's protocol. Each reaction mixture contained 2.5 µL of 2.5 mM dNTP mixture, 5.0 µL of 5x reverse transcriptase buffer, 2.0 µL of 0.1M Dithiothreitol (DTT), 0.5 µL RNasin (Promega) and 2.0 µL random hexamer primers (Roche Scientific). The final cDNA concentration was 1.8 µg/µL. Each sample was heated to 70°C for five minutes and then 4°C for five minutes in a MJ Research PTC-200 DNA Engine (MJ Research Inc. Watertown, MA, USA). At this time, 1 µL reverse transcriptase (Super Script II, Life Technologies, USA) was added to each sample and cycled at 37°C for sixty minutes, 90°C for five min and 4°C for five min. Samples were stored at -80°C until analysis with real-time RT-PCR less than 48 h after synthesis.
Real-time RT-PCR:
Primers for XOR (Forward: 5'CTGCAGGATGCCTGCCGCTT3'; Reverse: 5'GCATGG GCTTGGGTGCTGGT3') and Glyceraldehyde 3 -phosphate dehydrogenase (GAPDH) were designed using Primer 3 software (Howard Hughes Institute). Each sample was assayed in triplicate for the XOR and GAPDH primers on a 96-well plate. GAPDH (forward: 5'GACGTGCAGGAACACTA3'; reverse: 5'CTTGGACTT TGCCAGAGAGG3') was selected as a normalizer for this experiment as there were no differences in expression patterns due to treatment. A pooled sample, that contained cDNA samples from all treatments, was used for both analyses of both primer efficiencies. Primers were diluted to 5 µM/µL concentration in nuclease free water. A serial dilution was used to obtain a standard curve for each primer and efficiency was calculated. Primer efficiencies were determined from the slope of the regression line calculating the log of the cDNA concentrations versus the Ct value using the equation: E = 10
. The efficiencies were used to calculate the relative mRNA abundance using the "efficiency corrected relative expression" equation (Equation 3; Pfaffl, 2001 method employs uricase to generate H2O2 which reacts using the efficiency corrected relative expression method with 4-amino antipyrine (4-AAP) and TBHB in the (Pfaffl, 2001) .
presence of peroxidise to form a quinoneimine dye Xanthine oxidase and xanthine dehydrogenase change in absorbance at 520 nm is proportional to UA activities: Previously, tissue preparation and enzyme concentration in the sample. activity determination have been described in detail by Concentration of UA in liver and kidney samples was Settle et al. (2012) . Briefly, frozen tissue samples (0.5 g) measured using the technique described for PUA were homogenized in 4 mL of ice-cold 0.1 M TRIS buffer analysis using 40 µL of the supernatant fraction from the (pH = 7.8) using a Polytron PT 2100 (Kinematika AG, homogenization of tissues for XOR analysis. Briefly, Littau, Switzerland) for 20 s at 19,000 rpm. The tissues were homogenized in 2 mL of ice-cold 0.1 M homogenate was centrifuged (14000 x g, 4°C, 30 min) TRIS buffer (pH = 7.8) and centrifuged at 14000 x g at and 1 mL of the supernatant fraction was immediately 4°C for 30 min. Concentrations of UA were analyzed in chromatographed on Sephadex G-25 (PD-10 desalting 40 µL o f the supernatant fraction by the method colums; GE Healthcare, Piscataway, NJ, USA) and described previously. equilibrated with 1.5 mL of 0.1 M TRIS buffer (4°C). The eluates were stored on ice and assayed for XO and XD Statistical analyses: Tukey's multiple comparison test activities within 1-2 h after homogenizing the tissue.
was used to assess differences among means. All XO and XD activities were assayed by measuring the analyses were conducted using the PROC GLM of SAS formation of UA when xanthine was incubated with the (SAS institute, 2002) for both studies. Correlations eluates. Each eluate was incubated with 100 µ M between UA concentration in liver and kidney were xanthine in the presence of ambient oxygen (XO activity) determined by Pearson correlation analysis using or with 100 µM xanthine and 0.67 mM NAD (XO+XD the PROC CORR of SAS software. Significance was as + activity). The reaction mixture contained 200 µL of eluate p = 0.05. Statistical significance for gene expression and 2.8 mL of 0.1 M TRIS buffer (pH = 7.8) with 100 µM was assessed using the analysis of Variance (ANOVA) xanthine. The tubes containing the reaction mixtures procedure of the Ri 386 software. When significant were incubated at 41°C for 30 min and absorbance was differences occur (p<0.05), means were separated by measured at 294 nm in a Beckman Spectrophotometer the least squares mean procedure and then adjusted for DU 640 (Beckman Instruments, Fullerton, CA). The multiple comparisons using the Tukey's multiple amount of UA produced was determined from the comparison test. difference between the absorbance values at 30 and 0 min, as compared to external standards of known UA concentration. Blanks containing xanthine and xanthine plus NAD were incubated along with the sample tubes + to correct for nonenzymatic oxidation of xanthine. Each assay was performed in duplicate. One unit of activity was defined as the production of 1 nanomol of UA per min at 41°C and pH 7.8 using 100 µM xanthine as substrate in the presence (XO+XD activity) or absence of 0.67 mM NAD (XO activity). XD + activity was calculated as the difference between total (XO+XD) and XO activity. XO and XD activities are expressed as units per mg of protein, but XO and XD activity in total liver was calculated as units per g of liver multiplied by liver weight. Specific activities were expressed in terms of units per mg of protein in the eluate. The protein content in the eluate was assessed by Bio Rad Protein Assay (Bio-Rad Chemical Division, USA) on a spectrophotometer according to the method of Bradford (1976) using serum albumin as standard.
Uric acid analysis: As described by Settle et al. (2012) , the UA concentration in plasma was measured in the measured on a spectrophotometer. The resulting
RESULTS

Body weights, PUA, tissue uric acid and XOR activity:
Results for body mass, PUA, tissue uric acid and XOR activity have been reported by Settle et al. (2012) . Briefly, there were no differences (p = 0.853) in initial B M between the experimental groups (Table 1) , after 1 week of treatment BM of the control birds was higher (p<0.001) than that of the INO and INOAL birds. No differences (p>0.05) were detected between INO and INOAL groups As shown in Table 1 , PUA concentrations were similar (p = 0.847) in all groups at the onset of the study. After 3 days of treatment, INO birds had higher (p<0.001) PUA levels than controls and INOAL birds. The INOAL birds had significantly higher PUA levels than control birds. After 6 days of treatment, PUA concentrations remained elevated (p<0.001) in INO and INOAL birds as compared to control birds, but there were no differences (p>0.05) between INO and INOAL groups. The effects of experimental treatments on XO and XD activities and UA concentrations in the liver and kidney are shown in Table 2 and 3, respectively. After 6 days of treatment, INOAL birds had lower (p = 0.001) liver weights than birds in CON and INO groups, whereas no differences (p>0.05) between CON and INO groups were detected. In addition, there were no differences (p = 0.673 to 0.875) between treatments in XO, XD, or XO+XD activity at the end of the study. However, control birds had higher (p<0.05) total enzyme activity in the liver (units/liver) than INOAL birds, with no differences (p>0.05) measured between control and INO groups. Concentrations of UA in the liver of INOAL birds, expressed both in mg per g of tissue and as total mg in the liver, were lower (p<0.001) than those in the liver of control and INO birds, while there were no differences (p>0.05) between INO and CON birds.
mass (BM) and in broilers (n = 5) ---------------------Plasma uric acid (mg/dL) --------------------
No differences (p = 0.510 to 0.573) in UA existed between any of the groups in enzyme activity of the kidney were detected (Table 3) . Kidney UA concentrations in CON birds were lower (p<0.05) than those found in the INO treatment, but no difference (p>0.05) was detected between CON and As in previous studies (Della Corte and Stirpe, 1967 ; INOAL groups.
XOR gene expression:
There was an upregulation of XOR gene expression in liver tissue (Fig. 1) of the INOAL group when compared to both the CON (p = 0.007) and INO (p = 0.008) groups. There was no difference (p = 0.996) in XOR gene expression in the liver between CON and INO groups. There was no significant difference in kidney XOR (Fig. 2) gene expression between CON, INO and INOAL groups (p = 0.462, p = 0.906, p = 0.264, respectively).
DISCUSSION
The liver and kidney have been documented as sources of XOR activity in avian species (Harrison, 2002; Strittmatter, 1965; Carro et al., 2009b) . The most studied form of XOR is XD, which is the more readily available form in the tissues. Little attention has been paid to XO in birds, although it has been identified in several tissues including the liver, kidney, intestine and pancreas of broilers (Remy and Westerfield, 1951; Strittmatter, 1965; Carro et al., 2009a) . In this study, inosine, a precursor known to increase UA concentrations in birds (Simoyi et al., 2001) , was administered separately and in combination with allopurinol (Settle et al., 2012) . To our knowledge, this is the first study to investigate the effect of combining allopurinol and inosine on XOR activity, U A concentrations and XOR gene expression. As previously reported, the administration of inosine did not affect birds BM, but the INOAL birds showed a decreased final BM at the end of the study as compared with control and INO birds. This is in accordance with previous observations in birds fed the same allopurinol dose (Carro et al., 2009b) . Simoyi et al., 2002) birds in the INO group had common superscript differ (p<0.05). Error bars expression in birds. The chicken XD gene was first represent SEM for each treatment cloned by Sato et al. (1995) and was found to contain common superscript differ (p<0.05). Error bars been compromised by peroxynitrite damage (Hooper represent SEM for each treatment et al., 2000) . It is suggested that there is an increase in significantly higher PUA than controls after 3 and 6 days which may be directly related to the reduction in uric acid of treatment, with INOAL birds having intermediate PUA in the liver thereby causing a concomitant increase in the concentrations but higher than in controls. This XOR gene expression. suggests that allopurinol was unable to completely There was not a significant difference in the kidney inhibit XOR activity. Unexpectedly, liver UA concentrations tissue with respect to XOR gene expression, indicating were not affected by the administration of inosine, that there are tissue-specific differences in regulation of despite the higher UA concentrations observed i n UA. A study by Suzuki et al. (1984) using a rat model, plasma and kidney of INO birds compared with the suggested that liver and kidney tissue may show controls (3.2 and 7.1 times higher, respectively). These differences in sensitivity to allopurinol doses such that results suggest a different regulating mechanism of UA a range of 10-100 mg/kg BW/day can be toxic resulting concentrations in liver and kidney.
in hepatic necrosis and renal damage in some cases. Although it was reported that there were no differences
In the case of the kidney, it was found that relative kidney in the XOR activity in the liver between groups, when total weight, creatinine and BUN increased at doses above XO+XD activity in the liver was calculated, the INOAL 10 mg/kg BW, indicative of renal damage and it was birds showed significantly lower total enzyme activity, indicating that allopurinol was inhibiting enzyme activity as compared to control birds, which confirms the results observed in Settle et al. (2012) when birds fed diets containing allopurinol (25 mg/kg BW) were supplemented with uric acid exhibited no change in XO or XD activity, but demonstrated a reduction in total enzyme activity. In accordance with that observation, the birds in the INOAL group exhibited significantly lower UA concentrations in the liver as compared with control and INO b irds. This observation suggests a pronounced residual effect of allopurinol or oxypurinol, regardless of the presence of inosine which is converted into UA. The 1358 nucleotides. In this study, there was a significant induction of XOR gene expression in liver tissue o f INOAL b irds. Given that the liver UA content was significantly decreased it can be hypothesized that the liver may be vulnerable to oxidative damage due to a reduction in antioxidant defense. Simoyi et al. (2002) showed that a decrease in uric acid of the plasma can be linked to an increase in leukocyte oxidative activity, which suggests that the increase in XOR gene expression represents a compensatory mechanism to reduce oxidative damage to this tissue. A study b y Dupont et al. (1992) reported that there was an increase in XD/XO gene expression at the transcriptional level in rat endothelial cells under treatment with IFN-(, linking oxidative damage and inflammation in INOAL birds concluded that the kidney may be more sensitive to Carro, M.D., E. Falkenstein, K.P. Blemings and H . allopurinol, but the mechanism was not determined (Suzuki et al., 1984) . In birds uric acid is packaged in protein vesicles in the kidney before secretion (Braun and Dantzler, 1997) and the insoluble uric acid crystals are excreted along with fecal material from the cloaca (Skinner et al., 2001) . Uric acid is actively transported by MRP4 from the proximal tube epithelium (Bataille et al., 2008) . The mechanism of transport from the avian liver is, to our knowledge, unknown. These results also indicate that the regulation of uric acid differs between tissues.
Conclusion:
In conclusion, these studies show that allopurinol had a residual toxic effect in the liver and kidney, as indicated by chronically depressed U A concentrations in both tissues. The low UA tissue concentrations reported by Settle et al. (2012) are an indication of increased susceptibility to oxidative stress, due to the inverse relationship that UA has with oxidative stress. There was a significant increase in XOR gene expression in liver tissue, indicative that a reduction in concentrations of uric acid may initiate a compensatory up-regulation of the XOR gene to restore antioxidant protection to the tissue. However, this was not demonstrated in kidney tissue, which indicates that the mechanisms regulating UA production in liver and kidney may differ. Future work with the allopurinol model of inflammation will further increase our understanding of t he role that XOR has within the avian and the importance in the regulation of uric acid in the antioxidant defense system.
